ETHA Statement on Lessons learned from COVID-19: the need for better thrombosis management

ETHA contributes to the EU Non-Communicable Diseases Initiative

Statement from the International Society on Thrombosis and Haemostasis on Reports Indicating Blood Clots Associated with the AstraZeneca Vaccine

European Thrombosis and Haemostasis Alliance Welcomes European Medicines Agency Decision on COVID-19 Vaccination and Blood Clots

Saving and Improving Lives by Addressing Cancer-Associated Thrombosis

European Thrombosis and Haemostasis Alliance Elects Prof. Ingrid Pabinger-Fasching as Chair

Watch the Recorded Webinar on the Role of Public Affairs

Joint Statement on Cancer-Associated Thrombosis with the European Cancer Patient Coalition

ETHA Recognises World Thrombosis Day on 13 October

Consensus Statement: A Systematic Approach for Managing Venous Thromboembolism in Patients with COVID-19

Europe’s Beating Cancer Plan – Consultation Responses Submitted

ETHA Signs a Joint Statement on Cancer Comorbidities

ETHA Statement for Universal Health Coverage Day on 12 December

Cancer-Associated Thrombosis Roundtable Brings Together MEPs and Stakeholders

Proud to Partner: World Thrombosis Day on 13 October

Invitation: Cancer-Associated Thrombosis Roundtable Discussion at the EU | 16 October

ETHA Members Attend the 69th Session of the WHO Regional Committee for Europe

ETHA Celebrates World Patient Safety Day on 17 September

Giving the Thrombosis and Hemostasis Community a Voice to Drive Prioritisation

European Commission Relevant Calls for Proposals

ETHA: How Partnerships Can Increase Impact

ETHA Holds Inaugural Event at the European Parliament with Host MEP Aldo Patriciello

ETHA Issues Consensus Statement

European Thrombosis and Haemostasis Alliance Launches

World Thrombosis Day Impact Report Now Available

New Paper On Low Global Public Awareness of Atrial Fibrillation & Link To Stroke